The ethical problem of randomization

Internal and Emergency Medicine

Volumn 9, Issue 7, 2014, Pages 799-804

  Colli, Agostino ^a   Pagliaro, Luigi ^b   Duca, Piergiorgio ^c  

^a A MANZONI HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETHICS; HUMAN; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNCERTAINTY;

BIOMEDICAL RESEARCH; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNCERTAINTY;

EID: 84918537673     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-014-1118-z     Document Type: Editorial

References (36)

1. Comitato etico Orientamenti sull’utilizzo della randomizzazione nella sperimentazione clinica. Quaderni Fondazione Umberto Veronesi https://fondazioneveronesi.it/files/1313/8997/2853/Parere_Comitato_Etico_RANDOMIZZAZIONE_def17gennaio.pdf
2. A Medical Research Council investigation, Streptomycin in tuberculosis Trials Committee (1948) Streptomycin treatment of pulmonary tuberculosis. Br Med J 2(4582):769–782
3. Reith C, Landray M, Devereaux PJ, Bosch J, Granger C, Baigent C, Califf RM, Collins R, Yusuf S (2013) Randomized clinical trials—removing unnecessary obstacles. New Engl J Med 369:1061–1065
4. Mc Mahon AD, Conway DI, MacDonald TM, McIness GT (2009) The unintended consequences of clinical trials regulation. Plos Med 3:e1000131
5. Greenfield S, Kravitz R, Duan N, Kaplan SH (2007) Heterogeneity of treatment effects: implications for guidelines payment, and quality assessment. Am J Med 120(4A):S3–S9
6. Rothwell PM (2005) External validity of randomised controlled trials: “To whom do the results of this trial apply?”. Lancet 365:82–93
7. Kent DM, Hayward RA (2007) Stratification trials to individual patients: the need for risk stratification. JAMA 298(10):1209–1212 (doi:10.1001/jama.298.10.1209)
8. (2011) BIO/BioMed Tracker clinical trial success rates study. http://insidebioia.files.wordpress.com/2011/02/bio-ceo-biomedtracker-bio-study-handoutfinal-2-15-2011.pdf
9. Coxib and traditional NSAID Trialists (CNT) Collaboration (2013) Vascular and upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomized trial Lancet (http://www.thelancet.com/journalslancet/article/PIIS0140-6736(13)60900-9/fulltext)
10. Colli A, Fraquelli M, Casazza G, Conte D, Nikolova D, Duca PG, Thorlund K, Gluud C (2014) The architecture of diagnostic research: from bench to bedside. Research guidelines using liver stiffness as an example. Hepatology 60:408–418. doi:10.1002/hep.26948
11. Smith GCS, Pell JP (2003) Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 327:1459–1461
12. Djulbegovic B, Kumar A, Soares HP, Hozo I, Bepler G, Clarke Ml, Bennett CL (2008) Treatment success in cancer new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-Sponsored Cooperative Oncology Groups, 1955 to 2006. Arch Intern Med 168(6):632–642
13. Johnson N, Lilford JR, Brazier W (1991) At what level of collective equipoise does a clinical trial become ethical? J Med Ethics 17(1):30–34
14. Djulbegovic B, Bercu B (2002) At what level of collective equipoise does a clinical trial become ethical for the IRB members? Paper presented at: USF Third National Symposium, Bioethical Considerations in Human Subject Research; March 8, 2002; Clearwater, FL
15. Vist GE, Bryant D, Somerville L, Birminghem T, Oxman AD (2008) Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database of systematic Reviews, Issue 3. Art. No.: MR000009. doi:10.1002/14651858.MR000009.pub4
16. Majumdar SR, Roe MT, ED Peterson, Chen AY, Gibler WB, Armstrong PW (2008) Better outcomes for patients treated at hospitals that participate in clinical trials. Arch Intern Med 168(6):657–662
17. Pocock SJ, Elbourne DR (2000) Randomized trials or observational tribulations? N Engl J Med 342:1907–1909
18. Drazen JM, Gelijns AC (2014) Statin Strikeout. Engl J Med. doi:10.1056/NEJMe1405032
19. Lauer MS, D’Agostino RB (2013) The randomized registry trial—the next disruptive technology in clinical research? N Engl J Med 369:1579–1581
20. Fröbert O, Lagerqvist B, Olivecrona GK et al (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369:1587–1597
21. Young C, Horton R (2005) Putting clinical trials into context. Lancet 366:107–108
22. Montori VM, Devereaux PJ, Adhikari NKJ, Burns KEA, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E (2005) Guyatt, GH Randomized trials stopped early for benefit. A systematic review. JAMA 294:2203–2209
23. Darrow JJ, Avorn J, Kesselheim AS (2014) New FDA breakthrough-drug category—implications for patients. New Engl J Med 370:1252–1258
24. Kesselheim AS, Myers JA, Avorn J (2011) Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer. JAMA 305:2320–2326
25. Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK (1996) The impact of disease severity on the informed consent process in clinical research. Am J Med 100:261–268
26. Guyatt GH, Mills EJ, Elbourne D (2008) In the era of systematic reviews, does the size of an individual trial still matter? Plos Med 5(1):e4
27. Wetterslev J, Thorlund K, Brok J, Gluud C (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61:64
28. Public comment draft report of the patient—Centered Outcomes Research Institute (PCORI) Methodology Committee presented on July 23 (2012). http://www.pcori.org
29. Sobrero A, Bruzzi P (2009) Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval. J Clin Oncol 27(35):5868–5873
30. Devereaux PJ, Fahey T, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF, Nagpal S, Cox JL (2001) Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 323:1218–1222
31. Rothwell PM, McDowell Z, Wong CK, Dorman PJ (1997) Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. BMJ 314:1580–1583
32. Manzoli L, Flacco ME, D’Addario M, Capasso L, De Vito C, Marzuillo C, Villari P, Ioannidis JP (2014) A Non-publication and delayed publication of randomized trials on vaccines: survey. BMJ 348:g3058. doi:10.1136/bmj.g3058
33. Ladher N (2014) Secrets in healthcare. BMJ 348:g3439
34. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L (2012) Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews. Issue 12, Art. No.: MR000033. doi:10.1002/14651858.MR000033.pub2
35. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL (2003) Association of funding and conclusions in randomized drug trials. JAMA 290:921–928
36. Smith R (2005) Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2:e138